Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses 
Capital Markets Malaysia Expands Simplified ESG Disclosure Guide with a GHG Emission Calculator for SMEs 
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets 
EUDR Solution From Source Intelligence Simplifies Deforestation Due Diligence 
Spacely AI Secures US $1 Million Seed Round to Supercharge Generative AI Design for Architects Worldwide Beyond by BearingPoint Joins AWS ISV Accelerate Program
Program participation will enable Beyond’s customers to increase operational agility, accelerate speed to market, and…
Eurobio Scientific Receives a $430,000 Milestone Payment From Allergan
EUROBIO SCIENTIFIC RECEIVES A $430,000 MILESTONE PAYMENT FROM ALLERGAN Transition to clinical stage of a…
Covicept Therapeutics initiates a Phase 2 clinical study with PJS-539, an oral small molecule for the treatment of patients with COVID-19 (SARS-CoV-2)
Covicept Therapeutics initiates a Phase 2 clinical study with PJS-539, an oral small molecule for…
Biophytis to Host Virtual KOL Event on Sarconeos (BIO101) on its Lead Projects in COVID-19 and Sarcopenia
PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext…
Addex to Present at the Investors’ Day hosted by Voxia Communication
Geneva, Switzerland, October 6, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company…
Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week
Encouraging preclinical data support continued advancement of SZN-1326 towards first in human clinical studies in…
Eledon Pharmaceuticals Announces Upcoming Presentation on AT-1501 at the Virtual 2021 International Pancreas and Islet Transplantation Association Congress
IRVINE, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
Neuronetics Announces Commercial Agreement with Success TMS
MALVERN, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical…
Terns Pharmaceuticals to Present at H.C. Wainwright 5th Annual NASH Investor Conference
FOSTER CITY, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
CRISPR Therapeutics to Host Virtual Event Highlighting CTX110™ Clinical Data
–Management to host conference call and webcast on October 12th at 4:30 p.m. ET- ZUG,…
Oncternal Therapeutics Announced Pre-Clinical Data from ONCT-534, an Androgen Receptor N-Terminal-Domain-Binding Small Molecule Degrader, Was Accepted for Virtual Poster Presentation at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Androgen Receptor (AR) inhibition is an important therapeutic approach for the treatment of Castration-Resistant Prostate…
Shockwave Medical to Report Third Quarter 2021 Financial Results on November 8, 2021
SANTA CLARA, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Strongbridge Biopharma plc Announces Completion of Acquisition by Xeris Pharmaceuticals, Inc.
DUBLIN, Ireland and TREVOSE, Pa., Oct. 05, 2021 (GLOBE NEWSWIRE) — Strongbridge Biopharma plc (NASDAQ: SBBP) (the…
SEngine Precision Medicine and Gustave Roussy Announce Plan to Launch PARIS® Test in Europe
Prospective joint venture will accelerate precision medicine in Europe by harnessing innovations in high-throughput drug…
Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.
KEEGO HARBOR, Mich., Oct. 05, 2021 (GLOBE NEWSWIRE) — Zivo Bioscience, Inc. (NASDAQ: ZIVO, ZIVOW)…
Levitee Labs Publishes First Revenue Figures for August 2021
Levitee Labs achieves August 2021 revenues of $893,863 Levitee Clinics & Pharmacies achieves August 2021…
AXIM® Biotechnologies Appoints Senior DED Expert Dr. Laura Periman to its Medical Advisory Board
Dr. Periman Joins Chairman Joseph Tauber as Advisory Board’s Second Member SAN DIEGO, Oct. 05,…
TCR² Therapeutics Presents Preclinical Data on IL-15 Enhanced TRuCs at AACR Virtual Special Conference on Tumor Immunology & Immunotherapy
CAMBRIDGE, Mass., Oct. 05, 2021 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage…
Celsion Corporation Adds Key Resources to its Vaccine Development Initiative and Clinical Trial Capabilities
LAWRENCEVILLE, N.J., Oct. 05, 2021 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development…
CohBar to Present at H.C. Wainwright 5th Annual NASH Investor Conference
MENLO PARK, Calif., Oct. 05, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…